Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
August 2006
2006:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2007 | 2008
News | News in brief | News Features
News
Light shed on battle against HIV
Giving exhausted killer T cells a boost may be a simple mechanism to help them fight the HIV virus.
Nature (24 August 2006)
| Full Text |
What happens after the water recedes?
New Orleans universities are still struggling to recover from the ravages of Hurricane Katrina.
Nature (24 August 2006)
| Full Text |
Early embryos can yield stem cells... and survive
A new extraction technique could enable stem-cell lines to be generated without the controversial destruction of human embryos.
Nature (24 August 2006)
| Full Text |
AIDS meeting urged to rethink prevention strategy
Scientists, governments and funding agencies need to revise their strategy for deploying and testing HIV-prevention methods.
Nature (17 August 2006)
| Full Text |
Florida lures research institutes east
Florida is on a drive to recruit Californian research institutes, dangling tempting financial offers to persuade renowned laboratories to set up branches in the state.
Nature (17 August 2006)
| Full Text |
Homing in on the genes for humanity
HAR1F, a non-coding segment of the genome that has changed rapidly during human evolution, may harbour the secret of what makes humans different from our nearest primate relatives.
Nature (17 August 2006)
| Full Text |
Bundling next-generation cancer therapies for synergy
Biotech companies are now in a race to go beyond the limitations of existing targeted therapies either by finding complementary treatments or by combining already approved therapies to synergize their effect.
Nature Biotechnology (August 2006)
| Full Text |
Belated approval of first recombinant protein from animal
Atryn — a recombinant form of human antithrombin — is the first drug produced in an animal bioreactor to be approved by the European Medicines Agency (EMEA).
Nature Biotechnology (August 2006)
| Full Text |
Ethicists and biologists ponder the price of eggs
Should women be paid for the time, discomfort and health risks involved in donating eggs for research?
Nature (10 August 2006)
| Full Text |
Health effects of egg donation may take decades to emerge
Nature investigates what is known about the long-term health risks faced by donors.
Nature (10 August 2006)
| Full Text |
Plan for postdoc union sparks backlash
Postdocs at the University of California, one of the most influential US university systems, are embroiled in a debate over whether they should unionize.
Nature (10 August 2006)
| Full Text |
Silent running: the race to the clinic
A technique for turning genes off has sparked a flurry of biotech investment.
Nature (10 August 2006)
| Full Text |
Ambitious AIDS grants deepen rift between researchers
One year after the US National Institutes of Health (NIH) launched a project to develop an HIV vaccine, researchers are sorely split between those involved in the multimillion-dollar initiative—and everybody else.
Nature Medicine (August 2006)
| Full Text |
Frequent cases force China to face up to scientific fraud
The government is proposing new measures to combat misconduct and nepotism.
Nature Medicine (August 2006)
| Full Text |
Rules murky on DNA-based identification of disaster victims
Any research involving people requires that scientists go through a lengthy process of getting informed consent and approval from ethics panels. But does testing techniques on dead people constitute research?
Nature Medicine (August 2006)
| Full Text |
DDT returns
The most infamous pesticide in history is also the most effective weapon against malaria.
Nature Medicine (August 2006)
| Full Text |
Bird flu not set for pandemic, says US team
Simply mixing genes from an H5N1 bird-flu strain with those from an H3N2 human strain did not result in a strain that was readily transmissible, at least among ferrets.
Nature (3 August 2006)
| Full Text |
Singapore pulls plug on US collaboration
The city-state is shutting down a medical research arm of Johns Hopkins University in Singapore, claiming it has not delivered as planned.
Nature (3 August 2006)
| Full Text |
Mouse data hint at human pheromones
Results from a mouse study may bolster the evidence for human pheromones, the long-debated chemical signals thought to unconsciously sway our behavior.
Nature (3 August 2006)
| Full Text |
Home health tests are 'genetic horoscopes'
'Nutrigenetic' tests, combining diet advice with genetics testing, are at best ambiguous and at worst dangerous says the US Government Accountability Office (GAO).
Nature (3 August 2006)
| Full Text |
News in brief
Disgraced Korean cloner claims to be back in the lab
|National Cancer Institute appoints next director
|Transgenic grass strain escapes into the wild
| Animal-rights groups force researcher to quit studies
| Gates gift to Global Fund shames governments
| Electronic ark to hold all known animal species
| Toll-like receptor 3 deals
| Recombinant ice cream additive sparks controversy in Europe
| RNAi patent wars
| School board regains evolutionist majority
| Senators set sights on stem-cell legislation
| At last, a bird-flu vaccine that works at low doses
| UK centre offers cheap IVF in return for research eggs
| Conflicts-of-interest keep hitting US headlines
News Features
Appropriate technology: Make anything, anywhere
Can everyone use technology creatively? Engineers at the Massachusetts Institute of Technology think so and have launched 'Fab Labs' around the world to prove it.
Nature (24 August 2006)
| Full Text |
Neurodevelopment: How does the teenage brain work?
Changes in the structure of children's brains may account for some of the risky business of adolescence.
Nature (24 August 2006)
| Full Text |
Cancer: Caught in time
With research efforts under way to find better methods to detect minuscule tumors, Laura Spinney finds out how near some of these cancer 'biomarkers' are to the clinic.
Nature (17 August 2006)
| Full Text |
Cancer: Off by a whisker
Much of what we know about cancer comes from studying mice, and potential therapies are tested in the animals. But the differences between the species can scupper the best laid plans of researchers and drug companies.
Nature (17 August 2006)
| Full Text |
Cancer: The root of the problem
Is targeting cancer stem cells a way to finish tumors off once and for all — or just the latest in a long line of false dawns?
Nature (17 August 2006)
| Full Text |
Genetic profiteering
Consumers can pay a couple of hundred dollars to find out their ancestry or a couple of thousand dollars to find out their cancer risk.
Nature Bitoechnology (August 2006)
| Full Text |
AIDS treatment: Staying the course
Some feared that widespread use of AIDS treatments in Africa would encourage drug resistance, with globally disastrous consequences. But there's no crisis yet.
Nature (3 August 2006)
| Full Text |
Chemistry: What chemists want to know
Chemistry is a key component in all the scientific disciplines. But does that mean it is nothing more than a handy tool — or are there still major chemical questions to crack?
Nature (3 August 2006)
| Full Text |
|
